{'fraction_non_alphanumeric': 0.024242424242424242, 'fraction_numerical': 0.013636363636363636, 'mean_word_length': 5.544554455445544, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Poison Control System's 15-Year Experience of Multiple Dose-Activated Charcoal Administration.

The concept of administering multiple doses of activated charcoal (MDAC) in poisoned patients dates back to more than 35 years.1,2 Although approximately 18 years old, the latest version of a position statement and practice guidelines produced by a consensus panel of experts concluded that MDAC should be considered only if a patient has ingested a life-threatening amount of carbamazepine, dapsone, phenobarbital, quinine, or theophylline.3 We sought to examine under what circumstances MDAC is currently being used and any complications associated with its use.